Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Basel Medical (BMGL) Liabilities and Shareholders Equity: 2024-2025

Historic Liabilities and Shareholders Equity for Basel Medical (BMGL) over the last 2 years, with FY2025 value amounting to $13.3 million.

  • Basel Medical's Liabilities and Shareholders Equity rose 993.39% to $13.3 million in Q2 2025 from the same period last year, while for Jun 2025 it was $25.3 million, marking a year-over-year change of. This contributed to the annual value of $13.3 million for FY2025, which is 952.9% up from last year.
  • As of FY2025, Basel Medical's Liabilities and Shareholders Equity stood at $13.3 million, which was up 952.9% from $12.1 million recorded in FY2024.
  • Over the past 5 years, Basel Medical's Liabilities and Shareholders Equity peaked at $13.3 million during FY2025, and registered a low of $12.1 million during FY2024.